new developments in weight-loss drugs: novo nordisk, eli lilly & pfizer advance studies
Published 1 year ago • 11K plays • Length 6:14Download video MP4
Download video MP3
Similar videos
-
6:43
eli lilly ceo on weight loss drugs outlook: our top priority is making more product
-
3:54
former fda commissioner: expect more competition in eli lilly and novo nordisk's weight-loss drugs
-
19:20
how ozempic and wegovy accidentally made novo nordisk a $400b company
-
3:45
novo nordisk, eli lilly have strong first-mover advantage: analyst
-
5:53
eli lilly and novo nordisk will remain leaders in the weight-loss drug market: mizuho's jared holz
-
2:10
pfizer advances development of once-daily formulation of oral weight loss pill
-
4:17
barclays: novo nordisk and eli lilly have first-move advantage in the obesity drug race
-
0:55
pfizer ceo: weight loss pill may enter regulatory studies next year
-
0:55
eli lilly ceo on compounded versions of weight loss drugs
-
4:01
pfizer's weight loss pill may enter regulatory studies next year, says ceo albert bourla
-
4:35
jim cramer weighs the market impact of eli lilly and novo nordisk's weight loss drugs
-
5:06
eli lilly and novo can 'coexist for awhile' in the weight-loss drug space, says bmo's evan seigerman
-
5:47
zealand's obesity drug shouldn't disrupt novo nordisk-eli lilly leadership: mizuho's jared holz
-
5:24
eli lilly goes direct-to-consumer on weight loss drugs: what patients and investors need to know
-
6:29
dr. scott gottlieb on weight loss drugs side effects, eli lilly's direct-to-consumer bet
-
4:09
lilly pulls ahead of novo in obesity drug race
-
7:12
ozempic is a game-changer. here’s how it works.
-
2:49
eli lilly and novo nordisk are ahead in manufacturing but need time to meet demand, says louise chen
-
3:34
why are novo nordisk & eli lilly on the upswing? | weight-loss drugs | n18v